The DBA patients recruited carried mutations in various RP genes, including RPS19, RPS26, RPL5, RPL11, RPL15, and RPL35A. BM cells isolated from five healthy individuals were included as normal controls (NC; Supplementary Table S2). This evidence concerns the gene RPS26 and Diamond-Blackfan anemia.